Medical News

RSS

Orszag says new Medicare payment board will help lower deficit

"An Independent Payment Advisory Board (IPAB) established under the healthcare reform act will help to ensure the nation's future fiscal health, Office of Management and Budget Director Peter Orszag said Thursday," McKnight's Long Term Care News & Assisted Living reports. "If set up correctly, the Medicare payment board will contribute to a reduction in national health costs and the federal deficit, Orszag said before the Economic Club of Washington last week, according to the Bureau of National Affairs.

12 Apr 2010

Obese children have stiffer arteries than leaner counterparts

Children with more body fat and less endurance than their fitter, leaner counterparts have stiffer arteries at a young age, Medical College of Georgia researchers said.

12 Apr 2010

Carestream Molecular Imaging, OncoVision sign exclusive agreement for Albira PET/SPECT/CT imaging system

Carestream Molecular Imaging, a division of Carestream Health, Inc., has signed an exclusive, multi-year worldwide agreement with OncoVision (Valencia, Spain), to sell, market and service the Albira PET/SPECT/CT imaging system for small animal research. With the addition of this innovative, multimodal imaging system, Carestream Molecular Imaging will offer the broadest portfolio of pre-clinical in vivo imaging modalities in the market.

12 Apr 2010

Vancouver Coastal Health implements Kronos' workforce management solutions

Following a rapid implementation, 8,000 Vancouver Coastal Health employees are now live with workforce management solutions from Kronos® Incorporated. A regional healthcare provider serving 25 percent of British Columbia's population, Vancouver Coastal Health is continuing to implement Kronos for its entire workforce of 21,000+ employees. Kronos will be used in 556 locations.

12 Apr 2010

EDAP's Sonolith i-move lithotripter receives European approval

EDAP TMS SA, the global leader in therapeutic ultrasound, announced today the European approval of its new lithotripter, the Sonolith i-move. The EDAP sales team and distributors will begin marketing Sonolith i-move immediately and will officially introduce the product to distributors, partners and visiting urologists at the European Association Urology (EAU) congress, Booth #14, from April 17-19, 2010 in Barcelona, Spain.

12 Apr 2010

How will the health overhaul affect you?

Nonprofit and advocacy Web sites, online "chats" with government officials, and hotlines for lawmakers are getting barraged with questions about how the health law will affect Americans, Kaiser Health News reports. "No matter which source they turn to, consumers are asking about every element of the bill. People who don't have health care coverage want to know how they can enroll in the high-risk pools that are scheduled to be up and running within 90 days.

12 Apr 2010

Audiology NOW! 2010 Conference: Panasonic to announce entry into US Hearing Care market

Panasonic will today announce, at the Audiology NOW! 2010 Conference being held in this city, that it will enter the Hearing Care business in the U.S. market. The Conference, which is focused on hearing instruments and technologies to support audiologists and their patients, is the largest gathering of audiologists in the world. The company will make the announcement on site at its booth #2920 in the San Diego Convention Center.

From PHC Europe B.V. 12 Apr 2010

Aetna hit with penalty, suspended from signing up new Medicare members

The Wall Street Journal: Medicare officials have suspended the Aetna insurance company from enrolling new members for "its Medicare Advantage and Medicare prescription-drug plans because the insurer didn't comply with rules about changing drug-plan designs, the government said." The sanctions come after the government says the Connecticut-based insurance company did not "meet requirements to make sure seniors could continue on their medications during changes to the Aetna plans in 2009 and those offered this year."

12 Apr 2010

FDA approves Sinapis Pharma's IND for IV methamphetamine in treatment of acute stroke

Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.

12 Apr 2010

Americans asking: 'How will health reform help me?'

Kaiser Health News staff writer Mary Agnes Carey writes about the questions stemming from the new health reform law: "David wanted to know how the new health care overhaul law would impact retiree health care coverage.

12 Apr 2010

The Female Health Company declares quarterly cash dividend of $0.05 per share

The Female Health Company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share. The dividend is payable May 12, 2010 to stockholders of record as of April 23, 2010.

12 Apr 2010

Over 12,000 participants already registered for 25th Anniversary EAU Congress

The upcoming 25th Anniversary EAU Congress in Barcelona from April 16 to 20 promises to be one of the EAU's biggest meetings in recent years with around 12,100 participants already registered to attend the annual urological event.

12 Apr 2010

Rib-X Pharmaceuticals to present delafloxacin Phase 2 study data at 20th ECCMID

Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that an oral presentation of data for delafloxacin, its lead antibiotic candidate, will be given at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 10-14, in Vienna, Austria by Paul G. Ambrose, Pharm.D, FIDSA, Director, Institute for Clinical Pharmacodynamics, Ordway Research Institute.

12 Apr 2010

Medinox, Orient Europharma form partnering agreement for NOX-100 anti-hypotensive drug

Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.

12 Apr 2010

Inhibitex provides update on ongoing Phase II clinical trial of FV-100 for shingles

Inhibitex, Inc. today announced that the independent Data Safety Monitoring Board (DSMB) responsible for reviewing safety data from the Company's ongoing Phase II clinical trial of FV-100 met, as scheduled, after the Company had provided it with 30-day follow-up data on the first half of the patients that the Company plans to enroll in the trial.

12 Apr 2010

Vivakor board approve dividend for Regeneca International

Vivakor, Inc. announced today that its Board of Directors approved a dividend of shares of common stock of Regeneca International, Inc.. Vivakor previously received the shares from Regeneca in the fourth quarter of 2009 under a license agreement whereby Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to RegeneBlend, one of the new cutting-edge nutraceutical formulations developed by Vivakor.

12 Apr 2010

Eclipsys introduces Sunrise Enterprise 5.5 integrated software solutions for healthcare industry

Eclipsys Corporation, The Outcomes Company® today announced the availability of Sunrise Enterprise™ 5.5 — a rich suite of integrated software solutions that serves to differentiate Eclipsys™ and its client base within the healthcare industry.

12 Apr 2010

eDiets.com completes previously announced registered direct offering

eDiets.com, Inc. today announced that it has completed its previously announced registered direct offering to select institutional investors for an aggregate of 5,275,000 shares. The shares were priced at $1.00 per share, resulting in total net proceeds of approximately $4.7 million, after deducting placement agent fees and other offering expenses.

12 Apr 2010

Competitive Technologies to introduce Calmare pain therapy at medical conference

Competitive Technologies, Inc. announced today that it will hold a conference for the medical community on May 17, 2010, in Boston, Mass. at the Marriott Long Wharf Hotel from 9:00 a.m. to 3:30 p.m., to introduce CTT's Calmare® pain therapy to the medical community. Professor Giuseppe Marineo, MD, DSc., Researcher, Founding President of Delta Research and Development, Tor Vergata University of Rome, is the Italian inventor of the "Scrambler Therapy," the technology used in the Calmare medical device.

12 Apr 2010

ZYTO reports record net income of $171,362 for 2009

ZYTO Corp reported record financial results for the full fiscal year ended December 31, 2009, including its highest-ever annual revenues, operating income and earnings per share.

12 Apr 2010